Phosphatidylinositol-3 kinase-Akt-mammalian target of rapamycin signaling pathway mediates contractility of human endometriotic stromal cells: A promising new target for the treatment of endometriosis-associated fibrosis

被引:6
作者
Abe, Wakana [1 ]
Nasu, Kaei [1 ,2 ]
Tsuno, Akitoshi [1 ]
Kawano, Yukie [1 ]
Narahara, Hisashi [1 ]
机构
[1] Oita Univ, Fac Med, Dept Obstet & Gynecol, Idaigaoka 1-1, Yufu, Oita 8795593, Japan
[2] Oita Univ, Fac Med, Div Obstet & Gynecol, Support Syst Community Med, Oita, Japan
来源
GYNECOLOGY AND MINIMALLY INVASIVE THERAPY-GMIT | 2014年 / 3卷 / 04期
基金
日本学术振兴会;
关键词
Akt; contractility; endometriosis; mammalian target of rapamycin; phosphatidylinositol-3; kinase;
D O I
10.1016/j.gmit.2014.07.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess the involvement of phosphatidylinositol-3 kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR) on the extracellular matrix contractility of endometriotic cells. Materials and methods: The effects of wortmannin, LY294002, Akt inhibitor IV, and Ku-0063794 on the contractility of endometriotic cyst stromal cells (ECSCs) were investigated using collagen gel contraction assay. Results: All four inhibitors of PI3K-Akt-mTOR evaluated in the current study significantly inhibited the contractility of ECSCs. Conclusion: The current findings suggest that the PI3K-Akt-mTOR signaling pathway is involved in the development of endometriosis-associated fibrosis. The PI3K-Akt-mTOR signaling pathway is a promising target for the treatment of endometriosis. Copyright (C) 2015, The Asia-Pacific Association for Gynecologic Endoscopy and Minimally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:115 / 118
页数:4
相关论文
共 28 条
[1]   Smooth muscles are frequent components of endometriotic lesions [J].
Anaf, V ;
Simon, P ;
Fayt, I ;
Noel, JC .
HUMAN REPRODUCTION, 2000, 15 (04) :767-771
[2]   The PI3K Pathway As Drug Target in Human Cancer [J].
Courtney, Kevin D. ;
Corcoran, Ryan B. ;
Engelman, Jeffrey A. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) :1075-1083
[3]   The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer [J].
Dillon, R. L. ;
White, D. E. ;
Muller, W. J. .
ONCOGENE, 2007, 26 (09) :1338-1345
[4]   Targeting PI3K signalling in cancer: opportunities, challenges and limitations [J].
Engelman, Jeffrey A. .
NATURE REVIEWS CANCER, 2009, 9 (08) :550-562
[5]   Endometriosis [J].
Giudice, LC ;
Kao, LC .
LANCET, 2004, 364 (9447) :1789-1799
[6]  
GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391
[7]   Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor [J].
Guba, M ;
von Breitenbuch, P ;
Steinbauer, M ;
Koehl, G ;
Flegel, S ;
Hornung, M ;
Bruns, CJ ;
Zuelke, C ;
Farkas, S ;
Anthuber, M ;
Jauch, KW ;
Geissler, EK .
NATURE MEDICINE, 2002, 8 (02) :128-135
[8]   Upstream and downstream of mTOR [J].
Hay, N ;
Sonenberg, N .
GENES & DEVELOPMENT, 2004, 18 (16) :1926-1945
[9]   Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation [J].
Laschke, M. W. ;
Elitzsch, A. ;
Scheuer, C. ;
Holstein, J. H. ;
Vollmar, B. ;
Menger, M. D. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 149 (02) :137-144
[10]   Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis [J].
Laudanski, P. ;
Szamatowicz, J. ;
Kowalczuk, O. ;
Kuzmicki, M. ;
Grabowicz, M. ;
Chyczewski, L. .
HUMAN REPRODUCTION, 2009, 24 (08) :1880-1890